Posted On: 05/30/2016 8:11:25 PM
Post# of 72442
My answer to Amatuer17's FUD about Phase 3 taking too long to start.
Quote:
Since you like to compare things,
Oritavancin Phase 2 completion date: May 2008
https://clinicaltrials.gov/ct2/show/NCT005145...amp;rank=1
Oritavancin Phase 3 start date: December 2010
https://clinicaltrials.gov/ct2/show/NCT012527...amp;rank=1
SPA application date: March 26, 2010
http://www.accessdata.fda.gov/drugsatfda_docs...00MedR.pdf
SPA agreement date: November 30, 2010
http://www.firstwordpharma.com/node/809053#axzz4ABcs9svI
Both Oritavancin and Brilacidin are single-dose treatment for ABSSSI with QIDP designation.
(3)
(0)
Scroll down for more posts ▼
